FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for zoledronic acid from Mylan Institutional LLC under an abbreviated new drug application (ANDA), enabling the generic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Hypercalcemia of Malignancy
• Osteoporosis
• Paget Disease of Bone

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

SUPPL AP for ZOLEDRONIC ACID (ZOLEDRONIC ACID)